Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
Pharmacogenomics|December 26, 2006
HIV and pharmacogenomics in 2007Saye Khoo
Clinical Pharmacology and Therapeutics|December 22, 2022
Response to "A Case Report of Safe Coadministration of Amioradone With Short-Term Treatment Nirmatrelvir-Ritonavir"Catia Marzolini, Saye Khoo
Current Opinion in HIV and AIDS|April 18, 2009
Clinical application of the inhibitory quotient: is there a role in HIV protease inhibitor therapy?Alan Winston, Saye Khoo
Handbook of Clinical Neurology|April 2, 2018
HIV infection and strokeLaura Benjamin, Saye Khoo
Current Opinion in HIV and AIDS|November 5, 2021
Doravirine: its role in HIV treatmentAlexander J Stockdale, Saye Khoo
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 30, 2026
How pharmacokinetic/pharmacodynamic models can inform the development of new HIV medicationsShawn Edgar Miranda, Saye Khoo
Expert Opinion on Drug Metabolism & Toxicology|November 17, 2010
Pharmacokinetic evaluation of etravirineLaura Dickinson, Saye Khoo, David Back
Therapeutic Drug Monitoring|June 17, 2006
An update on therapeutic drug monitoring for antiretroviral drugsDavid Back, Sara Gibbons, Saye Khoo
Antiviral Research|August 12, 2009
Pharmacokinetics and drug-drug interactions of antiretrovirals: an updateLaura Dickinson, Saye Khoo, David Back
Current Opinion in HIV and AIDS|June 2, 2017
Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countriesKay Seden, Marta Boffito, Saye Khoo
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
Pharmacogenomics|December 26, 2006
HIV and pharmacogenomics in 2007Saye Khoo
Clinical Pharmacology and Therapeutics|December 22, 2022
Response to "A Case Report of Safe Coadministration of Amioradone With Short-Term Treatment Nirmatrelvir-Ritonavir"Catia Marzolini, Saye Khoo
Current Opinion in HIV and AIDS|April 18, 2009
Clinical application of the inhibitory quotient: is there a role in HIV protease inhibitor therapy?Alan Winston, Saye Khoo
Handbook of Clinical Neurology|April 2, 2018
HIV infection and strokeLaura Benjamin, Saye Khoo
Current Opinion in HIV and AIDS|November 5, 2021
Doravirine: its role in HIV treatmentAlexander J Stockdale, Saye Khoo
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 30, 2026
How pharmacokinetic/pharmacodynamic models can inform the development of new HIV medicationsShawn Edgar Miranda, Saye Khoo
Expert Opinion on Drug Metabolism & Toxicology|November 17, 2010
Pharmacokinetic evaluation of etravirineLaura Dickinson, Saye Khoo, David Back
Therapeutic Drug Monitoring|June 17, 2006
An update on therapeutic drug monitoring for antiretroviral drugsDavid Back, Sara Gibbons, Saye Khoo
Antiviral Research|August 12, 2009
Pharmacokinetics and drug-drug interactions of antiretrovirals: an updateLaura Dickinson, Saye Khoo, David Back
Current Opinion in HIV and AIDS|June 2, 2017
Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countriesKay Seden, Marta Boffito, Saye Khoo
Pageof 29